Latest Breaking News On - Craig collard - Page 1 : comparemela.com

Top 3 Health Care Stocks That May Crash In May - TransMedics Gr (NASDAQ:TMDX)

Top 3 Health Care Stocks That May Crash In May - TransMedics Gr (NASDAQ:TMDX)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Johnw hannaWaleed hassaneinTransmedics group incHeron therapeutics incTesting servicesCaredx incMedics groupChief executiveCaredx presidentHeron therapeuticsCraig collardChief executive officerFirst solar andStocks insiders are

Heron Therapeutics, Inc (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript

Heron Therapeutics, Inc (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

South carolinaUnited statesNorth carolinaTim chiangIra duarteCarl byrnesKevin warnerSerge berlangerWilliam forbesMelissa dorelUnidentified company representativeCapital oneHeron therapeutics incDevelopment officerHeron therapeuticsCall transcript may

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

SAN DIEGO, March 28, 2024 /PRNewswire/ Heron Therapeutics, Inc. , a commercial-stage biotechnology company, today announced that Craig Collard, Chief Executive Officer of Heron, will participate.

Ira duartePrnewswire heron therapeutics incExchange commissionHeron therapeutics incCraig collardChief executive officerNeedham virtual healthcareInvestor resourcesHeron therapeuticsPrivate securities litigation reform actMedia contactVice presidentChief financial

Biotech Stock News Bite - Heron Therapeutics, Inc (Nasdaq: HRTX) Higher on Fourth Quarter and Full-Year 2023 Financial Results

Biotech Stock News Bite - Heron Therapeutics, Inc. (Nasdaq: HRTX) Higher on Fourth Quarter and Full-Year 2023 Financial Results

Heron therapeutics incCrosslink life sciencesBiotech stock news bitesCraig collardChief executive officerAccess needlePrior approval supplementNew drug applicationExploring miningCrypto cornerCannabis news

Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates

/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results.

Heron biochronomerIra duartePrnewswire heron therapeutics incHeron therapeutics incEuropean unionExchange commissionWhile the companyCrosslink life sciencesDrug administrationCraig collardChief executive officerAccess needlePrior approval supplementNew drug applicationProduct revenuesAdjusted operating expenses